InvestorsHub Logo
Followers 39
Posts 1525
Boards Moderated 0
Alias Born 07/10/2014

Re: iReapZzYy post# 9951

Monday, 09/28/2015 11:39:00 PM

Monday, September 28, 2015 11:39:00 PM

Post# of 18784
Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October.

http://finance.yahoo.com/news/aeterna-zentaris-announces-data-safety-113000737.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News